News
11-24-2021, 05:19 PM
On November 23, 2021, the California Institute for Regenerative Medicine (CIRM) governing board approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
More... (https://www.news-medical.net/news/20211124/CIRM-awards-2441-million-to-advance-CAR-T-cell-therapy-from-the-lab-to-clinic.aspx)
More... (https://www.news-medical.net/news/20211124/CIRM-awards-2441-million-to-advance-CAR-T-cell-therapy-from-the-lab-to-clinic.aspx)